Back to Results
First PageMeta Content
Alcohols / Chronic obstructive pulmonary disease / Smoking / Naltrexone / Chemistry / Organic chemistry / Phenols


Briefing Book - aclidinium bromide Forest Research Institute, Inc. Page 2 of 172
Add to Reading List

Open Document

File Size: 1,19 MB

Share Result on Facebook

Company

TDI / Clinical Laboratory / Any Treatment Group / Forest Research Institute Inc. / ITT / /

Event

FDA Phase / /

MedicalCondition

Pneumonia / Patient With COPD / COPD / Patients With COPD / Cardiac Disorders / Anticholinergic Syndrome / Cardiac Failure / Cerebrovascular Disorders / RATIONALE FOR THE USE OF ACLIDINIUM BROMIDE IN COPD / Severe Chronic Obstructive Pulmonary Disease / /

Organization

Forest Research Institute / /

Person

Adverse Cardiac / /

Position

EXECUTIVE / /

Product

Rescue Medication / FEV1 / /

Technology

PHARMACOKINETICS / ADO / /

SocialTag